# Commission Regulation (EU) No 759/2010 of 24 August 2010 amending the Annex to Regulation (EU) No 37/2010 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin, as regards the substance tildipirosin (Text with EEA relevance), Annex

Extent: E+W+S+N.I.

In Table 1 of the Annex to Regulation (EU) No 37/2010, the following substance is inserted in alphabetical order:
Pharmacologically active substance
Marker residue
Animal species
MRL
Target tissues
Other provisions(according to Article 14(7) of Regulation (EC) No 470/2009)
Therapeutic classification
‘Tildipirosin
Tildipirosin
Bovine, caprine
400 μg/kg
Muscle
Not for use in animals from which milk is produced for human consumption.
The MRL for muscle shall not apply to the injection site, where residue levels shall not exceed 11 500 μg/kg.
Provisional MRL shall expire on 1 January 2012.
Macrolide’
200 μg/kg
Fat
2 000 μg/kg
Liver
3 000 μg/kg
Kidney
Porcine
1 200 μg/kg
Muscle
The MRL for muscle shall not apply to the injection site, where residue levels shall not exceed 7 500 μg/kg.
Provisional MRL shall expire on 1 January 2012.
800 μg/kg
Skin and fat
5 000 μg/kg
Liver
10 000 μg/kg
Kidney

---
Source: https://www.legislation.gov.uk/eur/2010/759/annex (the official version)
Page: https://openlegislation.uk/eu-regulation-2010-759/annex
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.